WOCKHARDT TO MANUFACTURE ARICEPT FOR EISAI PHARMACEUTICALS

The Mumbai-based Eisai Pharmaceuticals India has identified Wockhardt as the company's partner for the manufacture of its Alzheimer's drug Aricept (donepezil hydrochloride tablets) in India. Wockhardt will be manufacturing the drug in India on behalf of Eisai, which will be marketed exclusively by Eisai India in the country, said Deepak Naik, managing direcror, Eisai India. Aricept will be the second product that Wockhardt will be manufacturing in the country for Eisai, after Methycobal (mecobalamine) in India. Wockhardt also markets Methycobal in the country.

PharmaBiz (http://www.pharmabiz.com/article/detnews.asp?articleid=25777)